New drugs that target "zombie" tuberculosis (TB) cells are now a step closer, thanks to a new study led by the University of ...

Image=KCDC Amid the increased possibility of using artificial intelligence (AI) for care due to aging, a senior medication ...

A new study by University of Bath scientists has highlighted two new potential families of drug molecules that could open the ...

Tuberculosis remains the world's leading infectious killer, resulting in more than 1·25 million deaths in 2023 alone.1 During ...

A new article published in Nature offers a promising path toward a shorter, more effective treatment for tuberculosis (TB), a ...

Tuberculosis kills 1.3 million people each year, making it the deadliest infectious disease in the world, write KJ Seung and.

The drug regulator emphasised the importance of regulated distribution under the National TB Elimination Programme to ensure ...

Shionogi will pay BioVersys $6.3 million for developing BV500, BioVersys's drug candidate for non-tuberculous mycobacteria.

Here are six new drug shortages and discontinuations, according to drug supply databases from the FDA.

DRESS emphasize personalized care, topical therapies, and selective reintroduction protocols, offering hope for better ...

Current tuberculosis infection tests struggle to detect the disease in those with HIV. A common co-infection, HIV can hide TB ...

Centre may restrict distribution of anti-TB drugs through NTEP: Our Bureau, New Delhi Saturday, June 28, 2025, 08:00 Hrs [IST] The Central government may soon restrict the distrib ...